Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
-
New shot could replace daily pill for advanced breast cancer
Disease control Not yet recruitingThis phase 3 trial compares an injectable form of letrozole (given every 3 months) to the standard daily oral pill, both combined with ribociclib, in 300 postmenopausal women with advanced HR-positive, HER2-negative breast cancer. The goal is to see if the injection works as well…
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a Four-Times-a-Year shot replace daily pills for breast cancer?
Disease control Not yet recruitingThis study tests whether a new quarterly injection of letrozole delivers the same amount of medicine into the body as the standard daily pill. It involves 120 postmenopausal women who have already completed at least 4-5 years of hormone therapy for early breast cancer. The goal i…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC